Hyaluronic Acid / Sodium Hyaluronate

ID: hyaluronic_acid

Aliases: HYALURONIC ACID, HA, sodium hyaluronate, hyaluronan

Type: compound

Route/form: topical/oral/injectable/device route depends heavily on formulation and indication

Status: approved_device_or_supplement_context

Evidence level: human RCT

Best data tier: human controlled/review

Support scope: human, non-human/mechanistic, review/regulatory

Source types: government_review, human_rct, preclinical

Linked sources: 3

Broad outcomes: Gut / immune / inflammation, Muscle growth / performance / recovery, Skin / wound repair

Reading note: These are curation notes anchored to linked sources, not a clinical recommendation or protocol.

Targets / mechanism

Optimization domains

Research basis

Limits, risks, and missing evidence

Risk flags

Linked papers, labels, and reviews

  1. FDA: Dermal fillers, including hyaluronic acid fillers
    government_review / fda_dermal_fillers_hyaluronic_acid
    Regulatory and safety context for injectable hyaluronic acid dermal fillers.
  2. Oral hyaluronan relieves wrinkles and improves dry skin: a 12-week double-blinded placebo-controlled study
    human_rct / pubmed_oral_hyaluronic_acid_skin_2021
    Oral supplement context; product and molecular-weight specificity matter.
  3. High-molecular weight hyaluronic acid protects against colitis by remodeling microbiota and restoring barrier function
    preclinical / sciencedirect_hmw_ha_colitis_2026
    Molecular-weight-dependent hyaluronic acid colitis model.